Efficacy News and Research

RSS
FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Repurposed drug used to treat ovarian cancer gives positive results

Repurposed drug used to treat ovarian cancer gives positive results

Neuralstem doses final patient with NSI-566 stem cells in Phase II trial

Neuralstem doses final patient with NSI-566 stem cells in Phase II trial

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

Researchers one step closer to finding treatment for dengue fever

Researchers one step closer to finding treatment for dengue fever

Botanical Dietary Supplement Screening using NMR and MS

Botanical Dietary Supplement Screening using NMR and MS

Catylix, Aspira Scientific partner to develop and commercialize new fluorination products

Catylix, Aspira Scientific partner to develop and commercialize new fluorination products

New hope for people suffering from obesity and diabetes

New hope for people suffering from obesity and diabetes

Endo International revenues increase $719M to 1% in Q2 2014

Endo International revenues increase $719M to 1% in Q2 2014

ChromaDex to provide Murdoch Childrens Research Institute with NR ingredient for research use

ChromaDex to provide Murdoch Childrens Research Institute with NR ingredient for research use

Study to measure attitudes toward e-cigarettes among physicians treating adult smokers

Study to measure attitudes toward e-cigarettes among physicians treating adult smokers

Washington bioengineers discover potential method to protect women from contracting HIV

Washington bioengineers discover potential method to protect women from contracting HIV

Regeneron announces FDA approval of EYLEA Injection for DME treatment

Regeneron announces FDA approval of EYLEA Injection for DME treatment

Acupuncture helps cut fatigue, anxiety and depression in breast cancer patients using aromatase inhibitors

Acupuncture helps cut fatigue, anxiety and depression in breast cancer patients using aromatase inhibitors

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono begins MSB0010718C Phase II study in mMCC patients

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.